Almost 100 years elapsed after the discovery of dendritic cells in the human skin epithelium by Paul Langerhans in 1868 until the initiation of research on those cells was reinitiated. The present paper provides the milestones in the research on Langerhans/dendritic cells (LCs/DCs) between 1960 and 1989. This historical review will explain how researchers gradually discovered the role of the bone marrow-derived dendritic cells in the immune response. The paper is an appendix to the manuscript entitled: "Immunological and regulatory functions of uninfected and infected immature and mature subtypes of dendritic cells" (Virus Genes 26: 119-130, 2003).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1023/a:1023479212095 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Micronodular Thymic Carcinoma with Lymphoid Stroma: A Case Report.
Int J Surg Pathol
August 2023
Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Japan.
Micronodular thymic carcinoma (MTC) with lymphoid hyperplasia is believed to be the malignant counterpart of micronodular thymoma (MT) with lymphoid hyperplasia. Since MT and MTC share a similar morphology, MTC is considered a malignant form of MT; there have been a few malignant transformations from MT to MTC. We report a case of MTC with lymphoid hyperplasia.
View Article and Find Full Text PDFLangerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant.
Blood Adv
March 2022
Laboratory of Cellular Immunobiology, Sloan Kettering Institute for Cancer Research, New York, NY.
Posttransplant vaccination targeting residual disease is an immunotherapeutic strategy to improve antigen-specific immune responses and prolong disease-free survival after autologous stem cell transplantation (ASCT) for multiple myeloma (MM). We conducted a phase 1 vaccine trial to determine the safety, toxicity, and immunogenicity of autologous Langerhans-type dendritic cells (LCs) electroporated with CT7, MAGE-A3, and Wilms tumor 1 (WT1) messenger RNA (mRNA), after ASCT for MM. Ten patients received a priming immunization plus 2 boosters at 12, 30, and 90 days, respectively, after ASCT.
View Article and Find Full Text PDFPrimary Langerhans Cell Histiocytosis in Thyroid.
Acta Endocrinol (Buchar)
January 2020
Izmir Tepecik Training and Research Hospital - General Surgery, Izmir, Turkey.
Background: Langerhans cell histiocytosis (LCH) is a rare group of neoplastic diseases resulting from Langerhans dendritic cells. The most common site (80%) is bones. Thyroid gland involvement is exceedingly rare and usually expected to be seen as a part of multisystemic disease.
View Article and Find Full Text PDFBone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function.
J Allergy Clin Immunol
May 2021
Otto Loewi Research Center, Division of Immunology and Pathophysiology, Medical University of Graz, Graz, Austria. Electronic address:
Background: Bone morphogenetic proteins (BMPs) are members of the TGF-β family that signal via the BMP receptor (BMPR) signaling cascade, distinct from canonical TGF-β signaling. BMP downstream signaling is strongly induced within epidermal keratinocytes in cutaneous psoriatic lesions, and BMP7 instructs monocytic cells to acquire characteristics of psoriasis-associated Langerhans dendritic cells (DCs). Regulatory T (Treg)-cell numbers strongly increase during psoriatic skin inflammation and were recently shown to limit psoriatic skin inflammation.
View Article and Find Full Text PDFOccult Langerhans Cell Histiocytosis in Clear Cell Renal Cell Carcinoma.
Int J Surg Pathol
April 2018
1 Yeungnam University, Daegu, South Korea.
Langerhans cell histiocytosis is a rare disease that is characterized by a localized or systemic proliferation of Langerhans dendritic cells and a wide spectrum of clinical presentations. We experienced an unusual case of occult Langerhans cell histiocytosis associated with clear cell renal cell carcinoma. A 62-year-old man underwent a partial nephrectomy for left renal mass.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!